![GlycoMimetics Inc](/common/images/company/N_GLYC.png)
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1498 | 55.4814814815 | 0.27 | 0.4998 | 0.25 | 314189 | 0.27523482 | CS |
4 | 0.1668 | 65.9288537549 | 0.253 | 0.4998 | 0.2344 | 287333 | 0.27323255 | CS |
12 | 0.0698 | 19.9428571429 | 0.35 | 0.4998 | 0.1912 | 639154 | 0.27635459 | CS |
26 | 0.2388 | 131.933701657 | 0.181 | 0.63 | 0.1406 | 10284396 | 0.46773982 | CS |
52 | -2.6902 | -86.501607717 | 3.11 | 3.36 | 0.1406 | 6469822 | 0.47322971 | CS |
156 | -0.6502 | -60.7663551402 | 1.07 | 4.16 | 0.1406 | 2403726 | 0.63981794 | CS |
260 | -3.8202 | -90.0990566038 | 4.24 | 5.75 | 0.1406 | 1674481 | 0.96757442 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales